amyloid plaque

Galimedix's oral Alzheimer's candidate clears ph. 1 safety test

The small molecule caused no serious adverse events and successfully crossed the blood-brain barrier in a trial with more than 100 healthy volunteers.

Darren Incorvaia Sep 12, 2025 11:11am

Graphic of a brain inside of a lightbulb

Patient death prompts Roche to adjust Alzheimer's trial

Oct 30, 2024 11:40am

GE HealthCare claims FDA clearance for amyloid imaging software

Sep 18, 2024 11:00am

brain amyloid alzheimers strings detailed web complicated thought

FDA lays out donanemab concerns, Lilly vigorously defends safety

Jun 6, 2024 10:55am

Lauders give $200M to ADDF, the nonprofit's largest gift ever

Apr 5, 2023 11:16am

Lecanemab may have contributed to patient death: report

Oct 28, 2022 10:42am